Thx Pharma SA ALTHX.PA
€3.32
Last Updated: Jun 23, 12:00 AM·XPAR
Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
ALTHX.PA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 26, 2025
Report Source: 2024 Annual Report
Thx Pharma SA. Stock Analysis ALTHX.PA
France Health Care Micro Cap Report: THX Pharma engages in the design and development of drug candidates affecting the interaction between neurons and glial cells. The firm is an antisense oligonucleotide platform for the identification and characterization of therapy drug candidates co-constructed with laboratories in the field of neurological diseases. The first drug, TX01 for the disease of Niemann-Pick type C and Gaucher’s disease. The second drug, Batten-1, aims at the form juvenile of Batten disease and could be the first therapy considered in this form. The company has marketed its drugs notably in Europe and also in the United States, Canada and Australia.
Read More Thx Pharma SA (ALTHX.PA) Chart
Key Statistics of Thx Pharma SA (ALTHX.PA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€3.32Volume
86.15KP/E Ratio (TTM)
-52 Week Range
Market Cap
48.58MAvg. Volume
113.57KDividend Yield
-Financial Metrics & Statements of Thx Pharma SA (ALTHX.PA)
FAQ's for Thx Pharma SA (ALTHX.PA)
- According to Musaffa’s Shariah screening methodology, Thx Pharma SA (ALTHX.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Thx Pharma SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Thx Pharma SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Thx Pharma SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Thx Pharma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Thx Pharma SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.